Singapore’s AUM Biosciences, a VC-backed oncology treatments developer, has agreed to a NASDAQ listing via special purpose acquisition company (SPAC) at a pre-money equity valuation of USD 400m.
The SPAC, Mountain Crest Acquisition Corp V, raised USD 69m in late 2019. It is headed by Suying Liu, previously of US-based Mansion Capital and J.P. Morgan. Liu’s SPACs have targeted Asia as recently...
Fund-of-funds Quilvest Capital Partners was an early-mover in PE globally but has maintained a lean profile that speaks to its family office roots. It is pressing ahead with a China and India-focused Asia strategy
Indonesia’s EdenFarm is tackling Indonesia’s fragmented agribusiness space with a B2B fresh produce marketplace that not only helps distribute crops, but helps them grow in the first place
Accounting software provider Hnry has built up a following among freelancers and self-employed tradespeople in New Zealand and Australia. A USD 25m Series B will help it look further afield
For ChrysCapital Partners, raising India’s largest private equity fund reflects the growth in the economy and in the investment opportunity, with bigger deals across more sectors on the agenda